Medtronic (Minneapolis) stole the show in London this past weekend with results from a landmark clinical study showing that its IN.PACT Admiral drug-coated balloon outperformed standard balloon angioplasty in patients with peripheral artery disease (PAD) in the upper leg. Read More
